Szabó, K.M.; Tóth, A.; Nagy, L.; Nagy, L.T.; Sándorfi, G.; Clemens, M.; Nagy, A.C.; Ráduly, A.P.; Borbély, A.; Barta, J.;
et al. Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication. J. Clin. Med. 2025, 14, 6098.
https://doi.org/10.3390/jcm14176098
AMA Style
Szabó KM, Tóth A, Nagy L, Nagy LT, Sándorfi G, Clemens M, Nagy AC, Ráduly AP, Borbély A, Barta J,
et al. Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication. Journal of Clinical Medicine. 2025; 14(17):6098.
https://doi.org/10.3390/jcm14176098
Chicago/Turabian Style
Szabó, Krisztina Mária, Anna Tóth, László Nagy, László Tibor Nagy, Gábor Sándorfi, Marcell Clemens, Attila Csaba Nagy, Arnold Péter Ráduly, Attila Borbély, Judit Barta,
and et al. 2025. "Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication" Journal of Clinical Medicine 14, no. 17: 6098.
https://doi.org/10.3390/jcm14176098
APA Style
Szabó, K. M., Tóth, A., Nagy, L., Nagy, L. T., Sándorfi, G., Clemens, M., Nagy, A. C., Ráduly, A. P., Borbély, A., Barta, J., & Csanádi, Z.
(2025). Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication. Journal of Clinical Medicine, 14(17), 6098.
https://doi.org/10.3390/jcm14176098
